Bubs secures FDA approval to permanently supply US infant formula market
07 Sep 2026
Change in Director’s Notice – Lori Tauber Marcus
04 Sep 2026
Trading Halt
04 Sep 2026
Pause in Trading
04 Sep 2026
Change in Director’s Notice- Paul Jensen
03 Sep 2026
Change in Director’s Notice- Pascal De Petrini
03 Sep 2026
FY26 Results Presentation
27 Aug 2026
Appendix 4E Preliminary Final Report
27 Aug 2026
FY26 Results Commentary
27 Aug 2026
Notice of FY26 Results
04 Aug 2026
Q4 FY26 Quarterly Activities Report, Appendix 4C Cashflow Statement
31 Jul 2026
CFO Announcement
10 Jul 2026
View all announcements